Also trades as: DRMAW (NASDAQ) · $vol 0M
DRMA Earnings
Dermata Therapeutics, Inc.
1W: -2.6%
1M: -13.3%
3M: -17.2%
YTD: -49.1%
1Y: -78.4%
3Y: -93.2%
5Y: -99.9%
$1.10
-0.01 (-0.45%)
Weekly Expected Move ±4.7%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Last Earnings
2026-08-11
EPS
$-0.74
▼ Miss -34.5%
Revenue
—
Next Earnings
2026-11-18
EPS Estimate
$-0.46
Range: $-0.46 - $-0.46
Revenue Estimate
$75K
1 analysts
Estimate vs Actual
Earnings Surprise History
4/13
EPS Beats
0/13
Revenue Beats
31%
EPS Beat Rate
0%
Rev Beat Rate
Wall Street Forward Estimates
Quarterly
Annual
Estimate Revisions
Recent Revisions
| Date | Period | Fiscal Date | EPS Old | EPS New | Change | Rev Old | Rev New |
|---|---|---|---|---|---|---|---|
| 2026-08-20 | annual | 2027-12-31 | $-1.52 | $-1.43 | ▲ 0.09 | $750,000 | $750,000 |
| 2026-08-20 | annual | 2026-12-31 | $-2.21 | $-2.17 | ▲ 0.04 | $100,000 | $100,000 |
| 2026-08-20 | quarter | 2027-12-30 | $— | $-0.33 | ▼ 0.33 | $— | $300,000 |
| 2026-08-20 | quarter | 2027-09-30 | $— | $-0.35 | ▼ 0.35 | $— | $200,000 |
| 2026-08-20 | quarter | 2027-06-30 | $— | $-0.36 | ▼ 0.36 | $— | $150,000 |
| 2026-08-20 | quarter | 2027-03-30 | $— | $-0.42 | ▼ 0.42 | $— | $100,000 |
| 2026-08-20 | quarter | 2026-12-30 | $-0.56 | $-0.46 | ▲ 0.10 | $75,000 | $75,000 |
| 2026-08-20 | quarter | 2026-09-30 | $-0.63 | $-0.55 | ▲ 0.08 | $25,000 | $25,000 |
| 2026-08-12 | quarter | 2026-12-30 | $-0.65 | $-0.56 | ▲ 0.09 | $— | $75,000 |
| 2026-05-20 | quarter | 2026-12-31 | $-0.50 | $-0.56 | ▼ 0.06 | $75,000 | $75,000 |
| 2026-05-20 | annual | 2026-12-31 | $-2.20 | $-2.21 | ▼ 0.01 | $100,000 | $100,000 |
| 2026-05-20 | quarter | 2026-09-30 | $-0.61 | $-0.63 | ▼ 0.02 | $25,000 | $25,000 |
| 2026-05-20 | quarter | 2026-06-30 | $-0.57 | $-0.55 | ▲ 0.02 | $— | $— |
| 2026-05-20 | annual | 2027-12-31 | $-1.49 | $-1.52 | ▼ 0.03 | $750,000 | $750,000 |
| 2026-04-08 | quarter | 2026-09-30 | $-0.84 | $-0.61 | ▲ 0.23 | $— | $25,000 |
Earnings Call Transcripts
No transcripts available.